Hagan Joseph P is Chief Executive Officer of Regulus Therapeutics Inc.
Person profile
Roles
Regulus Therapeutics
Chief Executive Officer
Aurinia Pharmaceuticals
Director
Address
La Jolla, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Regulus Therapeutics Inc.
18 Jan 24
4
Regulus Therapeutics Inc.
17 Jan 24
4
Regulus Therapeutics Inc.
14 Aug 23
4
Aurinia Pharmaceuticals Inc.
23 May 23
4
Regulus Therapeutics Inc.
17 Jan 23
4
Aurinia Pharmaceuticals Inc.
20 May 22
4
Regulus Therapeutics Inc.
11 May 22
4
Regulus Therapeutics Inc.
26 Jan 22
4
Aurinia Pharmaceuticals Inc.
4 Jan 22
4
Aurinia Pharmaceuticals Inc.
16 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jan 24 | RGLS Regulus Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 1.1906 | 14,580 | 17.36 k | 57,112 |
12 Jan 24 | RGLS Regulus Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 71,692 |
12 Jan 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.3 | 249,000 | 323.70 k | 249,000 |
10 Aug 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.36 | 1,312,500 | 1.79 mm | 1,312,500 |
19 May 23 | AUPH Aurinia Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 10.58 | 272 | 2.88 k | 11,961 |
18 May 23 | AUPH Aurinia Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,733 | 0.00 | 12,233 |
18 May 23 | AUPH Aurinia Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 8,733 | 0.00 | 0 |
11 Jan 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.48 | 100,000 | 148.00 k | 100,000 |